Pandion Therapeutics Inc (PAND) Annual Balance Sheets

Annual · GAAP · USD millions
Access PAND quarterly Balance Sheets →
Examining balance sheet movements between Pandion Therapeutics Inc and reveals how Dec 31 2020 adjusts its asset composition and liability profile.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2020)
Assets
Cash & cash equivalent219.89
Cash & Short-term Investments219.00
Accounts receivable0.95
Prepaid Expense And Other Assets Current3.10
Total Current Assets223.94
Equipment/Property/Plant Net3.42
Restricted Cash Noncurrent0.50
Total Assets227.86
Liabilities
Accounts Payable, Current AC1.78
Other Liabilities, Current7.08
Total Current Liabilities8.86
Total Long-term Debt0.00
Other liabilities, Noncurrent4.28
Accrued Expenses And Other Liabilities Current3.28
Contract With Customer Liability Current3.80
Contract With Customer Liability Noncurrent3.76
Total Liabilities13.13
Stockholders' Equity
Common Stock Value0.03
Additional Paid In Capital Common Stock300.68
Retained Earnings / Accumulated Deficit-85.98
Non-controlling interests & other214.73
Total Stockholder's Equity214.73
Liabilities & Stockholder's Equity227.86
4 historic quarters locked

Sign in to unlock the full Pandion Therapeutics Inc balance sheet history.

About PAND Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.